Package 31722-736-30
Brand: efavirenz, emtricitabine and tenofovir disoproxil fumarate
Generic: efavirenz, emtricitabine and tenofovir disoproxil fumaratePackage Facts
Identity
Package NDC
31722-736-30
Digits Only
3172273630
Product NDC
31722-736
Description
30 TABLET, FILM COATED in 1 BOTTLE (31722-736-30)
Marketing
Marketing Status
Brand
efavirenz, emtricitabine and tenofovir disoproxil fumarate
Generic
efavirenz, emtricitabine and tenofovir disoproxil fumarate
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e4da0a36-7416-0c27-e053-2995a90a99f9", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064", "N0000185504", "N0000182140", "N0000182141", "N0000175462", "M0015066", "N0000009947"], "upc": ["0331722736305"], "unii": ["JE6H2O27P8", "G70B4ETF4S", "OTT9J7900I"], "rxcui": ["643066"], "spl_set_id": ["5f261872-d705-4549-a43d-2ad6b0164dc3"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-736-30)", "package_ndc": "31722-736-30", "marketing_start_date": "20220124"}], "brand_name": "Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate", "product_id": "31722-736_e4da0a36-7416-0c27-e053-2995a90a99f9", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "31722-736", "generic_name": "Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "EFAVIRENZ", "strength": "600 mg/1"}, {"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA203053", "marketing_category": "ANDA", "marketing_start_date": "20220124", "listing_expiration_date": "20261231"}